^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

BVX001

i
Other names: BVX001, BVX130-mcMMAF
News
Trials
Company:
BiVictriX Therap
Drug class:
Microtubule inhibitor, CD33-targeted antibody-drug conjugate, CD7-targeted antibody-drug conjugate
Related drugs:
News
Trials